ECM
ELGX

Endurant Capital Management’s Endologix Inc ELGX Stock Holding History

Endurant Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-33,501
Closed -$2.42M – 108
2017
Q1 		$2.42M Buy
+33,501
New +$2.22M 0.78% 38

Other funds holding ELGX

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Endurant Capital Management's ELGX Position: Q2 2017 in Review

Endurant Capital Management sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 33,501 shares — an estimated $2.42M sold.

Endurant Capital Management first reported a position in ELGX in Q1 2017 and held it in 1 quarter. The position peaked at $2.42M in Q1 2017. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

  • Endurant Capital Management reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
  • Endurant Capital Management sold 33,501 Endologix Inc shares in Q2 2017, an estimated $2.42M.
  • Endurant Capital Management first reported a position in Endologix Inc in Q1 2017 and held it in 1 quarter.
  • Endurant Capital Management's Endologix Inc position peaked at $2.42M in Q1 2017.
  • 111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on Endurant Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.